sciencenewsnet.in

The March edition of SLAS Discovery features the cover article, “Therapeutic and Vaccine Options for COVID-19: Status After 6 Months of the Disease Outbreak” by Christian Ogaugwu (Federal University Oye-Ekiti, Ekiti State, Nigeria ), Dawid Maciorowski, Subba Rao Durvasula, Ph.D., Ravi Durvasula, M.D., and Adinarayana Kunamneni, Ph.D. (Loyola University Medical Center, Maywood, IL, USA).

Announcement

University of Utah to speed process of bringing new therapeutics to patients

November 18, 2020 sarah Jonas Cancer, Clinical Accelerator, Clinical Trial, Drug Discovery, Oncology, Pharmacy, Technology Transfer, Therapeutic, Therapies

The Huntsman Cancer Institute, College of Pharmacy and PIVOT Center have partnered to establish the University of Utah Therapeutic Accelerator Hub. The new Accelerator will provide resources and expertise to researchers to support the process of translating research discoveries into innovative clinical applications.

Announcement

UCLA to lead statewide coalition to address COVID-19’s impact on communities at risk

October 5, 2020 sarah Jonas awareness and education, Black, Community Engagement, Coronavirus, covid, COVID-19, Health Disparities, Indigenous, Latino, Prevention, Therapies, Therapies trial, VACCINE TRIAL, Vaccine Trials, Vaccines, vulnerable communities, Vulnerable Groups

A coalition of 11 academic institutions and their community partners across California has received a $4.1 million grant from the NIH for a statewide community-engaged approach to addressing COVID-19 among populations that have been disproportionately affected by the pandemic.

Research Results

Glycans in the SARS-CoV-2 spike protein play active role in infection

September 23, 2020 sarah Jonas Coronavirus, coronavirus research, COVID-19, Glycans, SARS-CoV-2, Spike protein, Therapies, Vaccines

As researchers try to develop therapies/vaccines to combat SARS-CoV-2, the coronavirus spike protein is a major focus since it can bind to cells. Now, researchers reporting in ACS Central Science have uncovered an active role for glycans in this process, suggesting targets for vaccines and therapies.